The global actinic (solar) keratosis treatment market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Actinic keratosis is a rough, scaly patch on the skin caused due to years of sun exposure. It usually affects older adults and occurs most commonly on the face, lips, ears, back of hands, forearms, scalp and neck. The major factor contributing to the growth of the market is the increasing prevalence of actinic keratosis across the globe. 

According to the Skin Cancer Foundation, as of January 2022, an estimated 58 million Americans have one or more than one actinic keratosis. Furthermore, the market is growing due to new product launches and FDA approval. For instance, in September 2021, Almirall S.A. announced the commercial launch of Klisyri (tirbanibulin) in Germany and the UK. The drug was approved by the European Commission and the UK Medicines & Healthcare products Regulatory Agency (MHRA) in July and August of 2021 for the treatment of actinic keratosis (AK) of the face and scalp in adults.

Some major players operating in the market include Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2021, Biofrontera Inc. announced that the first subject has been enrolled in a Phase 1 study to evaluate the safety and tolerability of photodynamic therapy (PDT). The study was aimed at the treatment of actinic keratosis (AK) using three tubes of Ameluz together with the company’s BF-RhodoLED XL lamp.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Therapy

o By End-User

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape- Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., and Novartis International AG, among others. 

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Actinic (Solar) Keratosis Treatment Market Report by Segment

By Therapy

• Topical Medications

o Fluorouracil

o Imiquimod

o IngenolMebutate

o Others

• Procedures

o Photodynamic Therapy

o Laser

o Others

By End-User

    • Hospitals and Oncology Centers

    • Dermatology Clinics

    • Other

Global Actinic (Solar) Keratosis Treatment Market Report by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • South Korea

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa